NCT02467335
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Hamilton, New Jersey, United States
Clinical trial condition
Infection, Human Immunodeficiency Virus
Explore clinical trials studying Infection, Human Immunodeficiency Virus. Study availability and eligibility vary by location and protocol.
107 public trials
1 recruiting study
Infection, Human Immunodeficiency Virus trial results
NCT00453440
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Woolwich, London, London, United Kingdom
- GSK Investigational Site Birmingham, Warwickshire, United Kingdom
- GSK Investigational Site Birmingham, United Kingdom
- GSK Investigational Site London, United Kingdom
NCT02666053
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Austin, Texas, United States
NCT01101893
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Buffalo, New York, United States
NCT02095886
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Nottingham, United Kingdom
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Nottingham, United Kingdom
Completed
Prospective Epidemiological Study Of The Prevalence Of HLAB*5701 In HIV-1 Infected Patients
NCT00441688
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
Not specified
NCT02666001
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Orlando, Florida, United States
- GSK Investigational Site Overland Park, Kansas, United States
NCT02063360
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
Not specified
NCT02893488
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Overland Park, Kansas, United States